Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica, 2005.

Unidad de Microscopía Electrónica, Universidad de Costa Rica, 2005.

Konturek SJ, Konturek PC, Pieniazek P, Bielanski W. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. J Physiol Pharmacol 1999; 50(5):683-94.

Sachs G, et al. Urel regulates the amonia production of Helicobacter pylori. Science 2000; 287:482-5.

Berger A. Scientists discover how Helicobacter survives gastric acid. BMJ 2000; 320:268.

Pounder RE, Ng D. the prevalence of Helicobacter pylori infection in the different countries. Aliment Pharmacol Ther 1995; 9:833-9.

Dominici P, Bellentani S, Di Biase Anna Rita, Saccoccio G, Le Rose et al. Familia cluestring of Helicobacter pylori infection: population based study. BMJ 1999; 319:537-41.

Martin JB. The role of Helicobacter pylori in gastritis and its progress to peptic ulcer disease. Aliment Pharmacol Ther 1995; 9:27-30.

Jaakimainen RL, Boyle E, Tudiver F. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. BMJ 1999; 319:1040-4.

Lee A, Dixon MF, Danon SJ, Kuipers E, Megraud F, Larwsson M, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7:461-5.

Paniagua Estévez M, Grá Oramas B, González-Carbajal Pascual M, Pereiras Costa R, Piñol Jiménez F y Valdés Alonso L. Otras formas de gastritis crónica. Gastrum 1997; (142): 17-23

Han SW, Evans DG, el-Zaatari FA, Go MF, Graham DY. The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer. Am J Gastroenterol 1996; 91:1135-7.

Oderda G, Palli D, Saieva C, Chiorboli E, Bona G. Short stature and Helicobacter pylori infection in Italian children prospective multicentre hospital based case-control study. BMJ 1998; 317:514-5.

Annibale B, Marignani M, Monarca B, Antonelli G, Marcheggiano A, Martino G, et al. Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med 1999; 131:668-72.

Muhlestein JB. Bacterial infections and atherosclerosis. J Investig Med 1998; 46:396-402.

Das UN. Hypothesis: cis-unsaturated fatty acids as potential anti-peptic ulcer drugs. Prostaglandins Leukot Essent Fatty Acids 1998; 58:377-80.

Pérez-Pérez GI, Brown WR, Cover TL, Dunn BE, Cao P, Martin JB. Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. Clin Diagn Lab Immunol 1994; 1:325-9.

Boccio J, Zubillaga M. Helicobacter pylori. Conceptos actuales. Editorial. APPTLA 1997; 47:194-6.

Zubillaga M, Oliverti P, Calcagno ML, Coldman C, Caro R, Mitta A, et al. Min 14C-UBT: A combination of gastric basal transit and 14C-Urea Breath Test for the detection of Helicobacter pylori infection in human beings. Nuclear Med Biol 1997; 24:565-9.

Curren European concepts in the management of Helicobacter pylori infection, the Maastricht consensus report. Gut 1997; 41:8-13.

Bardhan KD, Dallaire C, Eisold H, Duggan AE. Ranitidine bismuth citrate with clariteomycin for the treatment of duodenal ulcer. Gut 1997; 41:181-6.

Lane A. et All. Impact of Helicobacter pylori erradication on dyspepsia, health resource use, and quality of life in the Bristol Helicobacter project: randomised controlled trial. BMJ 2006; 332:199-204. 

Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Batyerdoerffer E, O'Morain C, et al. Erradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996; 1:138-44.

McColl KE, What remaining questions regarding Helicobacter pylori and associated diseases should be addressed by future research view from Europe. Gastroenterology 1997; 113:5158-62.

ANEXOS

ANEXO 1

ANEXO 2